MRI Interventions Inc (MRIC):企業の製品パイプライン分析2018

◆英語タイトル:MRI Interventions Inc (MRIC) - Product Pipeline Analysis, 2018 Update
◆商品コード:DATA904C2871
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD1,500 ⇒換算¥162,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥243,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MRI Interventions Inc (MRI Interventions) is a medical equipment company that develops and commercializes platforms for performing invasive surgical procedures. The company’s products include systems used for performing invasive surgeries on brain and heart. Its products are used for treating neurological and cardiac diseases. MRI Interventions’ product provides real time MRI assistance for certain invasive procedures in the brain. The company has partnership with various medical device companies and academic institutions for the development and commercialization of its product platforms and core technologies. It serves physicians and hospitals. MRI Interventions is headquartered in Irvine, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company MRI Interventions Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
MRI Interventions Inc Company Overview 5
MRI Interventions Inc Company Snapshot 5
MRI Interventions Inc Pipeline Products and Ongoing Clinical Trials Overview 5
MRI Interventions Inc – Pipeline Analysis Overview 8
MRI Interventions Inc – Key Facts 8
MRI Interventions Inc – Major Products and Services 9
MRI Interventions Inc Pipeline Products by Development Stage 10
MRI Interventions Inc Pipeline Products Overview 12
ClearAblate – Pancreas/Liver 12
ClearAblate – Pancreas/Liver Product Overview 12
ClearAblate – Pancreatic Cancer 13
ClearAblate – Pancreatic Cancer Product Overview 13
ClearAway – Intracerebral Hemorrhage 14
ClearAway – Intracerebral Hemorrhage Product Overview 14
ClearPoint – Adjustable Drug Delivery Cannula 15
ClearPoint – Adjustable Drug Delivery Cannula Product Overview 15
ClearPoint Electrode Placement Device – Alzheimer’s Disease 16
ClearPoint Electrode Placement Device – Alzheimer’s Disease Product Overview 16
ClearPoint Electrode Placement Device – Severe Depression 17
ClearPoint Electrode Placement Device – Severe Depression Product Overview 17
ClearPoint Software 2.0 18
ClearPoint Software 2.0 Product Overview 18
ClearTrace Cardiac Intervention System 19
ClearTrace Cardiac Intervention System Product Overview 19
MRI-safe Myocardial Biopsy Forcep 20
MRI-safe Myocardial Biopsy Forcep Product Overview 20
Smartflow Flex Ventricular Catheter 21
Smartflow Flex Ventricular Catheter Product Overview 21
MRI Interventions Inc – Key Competitors 22
MRI Interventions Inc – Key Employees 23
MRI Interventions Inc – Locations And Subsidiaries 24
Head Office 24
Recent Developments 25
MRI Interventions Inc, Recent Developments 25
May 29, 2018: MRI Interventions” ClearPoint Neuro Navigation System to Be Featured at ASSFN Biennial Meeting 25
May 17, 2018: MRI Interventions Announces CE Mark for the SmartFlow Cannula 25
May 15, 2018: MRI Interventions Announces First Quarter 2018 Results 26
Mar 15, 2018: MRI Interventions Reports 34% Year-Over-Year Increase in Functional Neurology Revenues, 50% increase in Capital Sales 27
Feb 06, 2018: MRI Interventions Announces Record 629 ClearPoint Cases in 2017 29
Jan 24, 2018: MRI Interventions Recognizes FDA Clearance of Voyager’s Investigational New Drug Application for VY-AADC Allowing its Pivotal Program to Begin for Advanced Parkinson’s Disease 30
Jan 11, 2018: EarlySense Percept Wins Best of Baby Tech Award at CES 31
Jan 03, 2018: MRI Interventions ClearPoint Neuro Navigation System Utilized for the First Time in Minnesota 31
Nov 16, 2017: MRI Interventions’ ClearPoint NeuroNavigation System Achieves 2000th Procedure Milestone 32
Nov 13, 2017: MRI Interventions ClearPoint Neuro Navigation System to be Featured at SNO/SCIDOT Joint Conference on Therapeutic Delivery to the CNS 32
Appendix 33
Methodology 33
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
MRI Interventions Inc Pipeline Products and Ongoing Clinical Trials Overview 5
MRI Interventions Inc Pipeline Products by Equipment Type 6
MRI Interventions Inc Pipeline Products by Indication 7
MRI Interventions Inc, Key Facts 8
MRI Interventions Inc, Major Products and Services 9
MRI Interventions Inc Number of Pipeline Products by Development Stage 10
MRI Interventions Inc Pipeline Products Summary by Development Stage 11
ClearAblate - Pancreas/Liver - Product Status 12
ClearAblate - Pancreas/Liver - Product Description 12
ClearAblate - Pancreatic Cancer - Product Status 13
ClearAblate - Pancreatic Cancer - Product Description 13
ClearAway - Intracerebral Hemorrhage - Product Status 14
ClearAway - Intracerebral Hemorrhage - Product Description 14
ClearPoint - Adjustable Drug Delivery Cannula - Product Status 15
ClearPoint - Adjustable Drug Delivery Cannula - Product Description 15
ClearPoint Electrode Placement Device - Alzheimer's Disease - Product Status 16
ClearPoint Electrode Placement Device - Alzheimer's Disease - Product Description 16
ClearPoint Electrode Placement Device - Severe Depression - Product Status 17
ClearPoint Electrode Placement Device - Severe Depression - Product Description 17
ClearPoint Software 2.0 - Product Status 18
ClearPoint Software 2.0 - Product Description 18
ClearTrace Cardiac Intervention System - Product Status 19
ClearTrace Cardiac Intervention System - Product Description 19
MRI-safe Myocardial Biopsy Forcep - Product Status 20
MRI-safe Myocardial Biopsy Forcep - Product Description 20
Smartflow Flex Ventricular Catheter - Product Status 21
Smartflow Flex Ventricular Catheter - Product Description 21
MRI Interventions Inc, Key Employees 23
Glossary 35

List of Figures
MRI Interventions Inc Pipeline Products by Equipment Type 6
MRI Interventions Inc Pipeline Products by Development Stage 10

★海外企業調査レポート[MRI Interventions Inc (MRIC):企業の製品パイプライン分析2018]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Apex Frozen Foods Limited (APEX):企業の財務・戦略的SWOT分析
    Apex Frozen Foods Limited (APEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Yanchang Petroleum International Ltd (346):企業の財務・戦略的SWOT分析
    Yanchang Petroleum International Ltd (346) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Chromalloy Gas Turbine LLC:企業の戦略・SWOT・財務情報
    Chromalloy Gas Turbine LLC - Strategy, SWOT and Corporate Finance Report Summary Chromalloy Gas Turbine LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Protea Biosciences Group Inc (PRGB)-医療機器分野:企業M&A・提携分析
    Summary Protea Biosciences Group Inc (Protea) is a biotechnology company that develops mass spectometry solutions. The company offers technology for the characterization, identification, and quantitation of biologically-important molecules for research, pharmaceutical development, and diagnostic app …
  • NantKwest Inc (NK):製薬・医療:M&Aディール及び事業提携情報
    Summary NantKwest Inc (NantKwest), a subsidiary of NantWorks LLC, formerly Conkwest Inc, is a clinical-stage immunotherapy company that develops therapeutic treatments for cancer, infectious diseases, and inflammatory diseases. The company utilizes its immuno-oncology NK platform to destroy the tumo …
  • Calamos Asset Management, Inc.
    Calamos Asset Management, Inc. - Strategy, SWOT and Corporate Finance Report Summary Calamos Asset Management, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • North China Pharmaceutical Co Ltd (600812):製薬・医療:M&Aディール及び事業提携情報
    Summary North China Pharmaceutical Co Ltd (NCPC), a subsidiary of North China Pharmaceutical Group Corp is a pharmaceutical company that develops, produces and sells novel drugs and pharmaceutical related products. The company offers preparation products, nutrition, pharmaceutical raw materials and …
  • Axela Inc:医療機器:M&Aディール及び事業提携情報
    Summary Axela Inc (Axela), formerly Axela Biosensors Inc is a provider of optic technology solutions. The company offers Ziplex system, Flow-thru TipChips, panelPlus TipChips, diffractive optics technology, diffractive optics sensors, panelPlus sensors and software products. It offers technical and …
  • Metalico Inc:企業の戦略的SWOT分析
    Metalico Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Cimab SA-製薬・医療分野:企業M&A・提携分析
    Summary Cimab SA (Cimab) is a biopharmaceutical company that develops and markets monoclonal antibodies and other recombinant proteins for the diagnosis and treatment of cancer and other diseases related to the immune system. The company offers products such as cimaher nimotuzumab, ior epocim epoeti …
  • Maruti Suzuki India Limited:企業の戦略・SWOT・財務情報
    Maruti Suzuki India Limited - Strategy, SWOT and Corporate Finance Report Summary Maruti Suzuki India Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Hang Seng Bank Ltd:企業の戦略・SWOT・財務情報
    Hang Seng Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary Hang Seng Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • International Data Group:戦略・SWOT・企業財務分析
    International Data Group - Strategy, SWOT and Corporate Finance Report Summary International Data Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Dorchester Minerals LP Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Dorchester Minerals LP Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Dorchester Minerals LP Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive info …
  • Concho Resources Inc (CXO):石油・ガス:M&Aディール及び事業提携情報
    Summary Concho Resources Inc (Concho) is an oil and gas company that acquires, develops and explores oil and natural gas properties. The company owns and operates exploration assets in the Permian Basin region of Southeast New Mexico and West Texas, an onshore oil and natural gas basin in the US. Co …
  • Aldermore Bank Plc:企業の戦略・SWOT・財務分析
    Aldermore Bank Plc - Strategy, SWOT and Corporate Finance Report Summary Aldermore Bank Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Global Payments Inc. (GPN):企業の財務・戦略的SWOT分析
    Global Payments Inc. (GPN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Amicus Therapeutics Inc (FOLD):企業の財務・戦略的SWOT分析
    Amicus Therapeutics Inc (FOLD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Teck Resources Ltd:企業のM&A・事業提携・投資動向
    Teck Resources Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Teck Resources Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • DTE Energy Co (DTE):電力:M&Aディール及び事業提携情報
    Summary DTE Energy Company (DTE Energy) is a diversified energy company that develops and manages energy-related businesses and services. It has presence in the electricity value chain from generation, procurement, to transmission, distribution, and sales. The company procures, stores, and transport …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆